News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Genmab A/S (GEN.CO) Announces Duobody And Hexabody Platform Collaboration With Undisclosed Biotechnology Company


6/4/2014 9:23:06 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Copenhagen, Denmark; June 4, 2014 – Genmab A/S (OMX: GEN), together with its subsidiary, Genmab B.V., announced today a research collaboration with an undisclosed Biotechnology company which would use and evaluate Genmab’s proprietary antibody technologies, the DuoBody and HexaBody platforms.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES